Cerus reported $32.31M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Atrion ATRI:US 16.44M 15.83M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Cerus CERS:US $ 32.31M 6.06M
Cytori Therapeutics CYTX:US $ 18.09M 3.15M
Haemonetics HAE:US $ 214.95M 44.55M
Meridian Bioscience VIVO:US $ 83.49M 82.47M
Nuvasive NUVA:US $ 225.98M 20.67M
Orasure Technologies OSUR:US $ 66.16M 4.56M
Quidel QDEL:US $ 379M 896.54M
Sientra SIEN:US $ 24.99M 13.89M
Staar Surgical STAA:US $ 202.49M 9.42M
Terumo 4543:JP Y 209566M 4315M
Utah Medical Products UTMD:US $ 66.22M 1.9M